GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (OTCPK:SRBCF) » Definitions » Other Net Income (Loss)

Sirona Biochem (Sirona Biochem) Other Net Income (Loss) : $0.00 Mil (TTM As of Jan. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sirona Biochem Other Net Income (Loss)?

Sirona Biochem's Other Net Income (Loss) for the three months ended in Jan. 2024 was $0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jan. 2024 was $0.00 Mil.

Sirona Biochem's quarterly Other Net Income (Loss) increased from Jul. 2023 ($-0.00 Mil) to Oct. 2023 ($0.00 Mil) and increased from Oct. 2023 ($0.00 Mil) to Jan. 2024 ($0.00 Mil).

Sirona Biochem's annual Other Net Income (Loss) increased from Oct. 2021 ($-0.00 Mil) to Oct. 2022 ($0.00 Mil) but then declined from Oct. 2022 ($0.00 Mil) to Oct. 2023 ($-0.00 Mil).


Sirona Biochem Other Net Income (Loss) Historical Data

The historical data trend for Sirona Biochem's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem Other Net Income (Loss) Chart

Sirona Biochem Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sirona Biochem Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sirona Biochem Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sirona Biochem Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Sirona Biochem's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Sirona Biochem (Sirona Biochem) Business Description

Traded in Other Exchanges
Address
C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L3
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.

Sirona Biochem (Sirona Biochem) Headlines